Tanomed has developed a unique nasal spray to relieve and prevent the progression of the common cold by reinforcing the body’s own defenses. The patented technology is based on Swedish research carried out in cooperation with Umeå University and with business development support from the Umeå Biotech Incubator. The company was sold to Karo Bio AB in spring 2015.

For how many years did you work with the incubator team?

“Three years and eight months.”

What happened to your idea in the end? 

“The company has been sold and the new owners are doing further research with the patent.”

What did you most appreciate about the incubator environment?

“I really enjoyed both UBI’s quality assurance and its working environment. I didn’t sit at UBI permanently, but when I was there I always felt welcome.”

What learnings have you taken with you from your journey in the incubator?

“That it is important to always quality assure processes and document what you work with. The DHF (design history file) must be documented for it to become a correct development process. In addition to that, access to the laboratory was also valuable.”

What would you say to others wanting to utilise a research idea?

“Don’t quality assure your own incompetence, adopt UBI’s program instead. It’s good and increases the chances of successful development.”


The company was sold to Karo Bio AB in spring 2015.

UBI Incubation Phase


Contact Information

Jean Lycke
Management and marketing adviser - Life Science